Recent Posts

1. 

   Tough times

   McKinsey is a plague. Of course we're dumb enough to pay them tens of millions of dollars and turn us into Valeant 2.0.

   Bristol-Myers Squibb

   anonymous

   Apr 23, 2024 at 10:04 PM

2. 

   Hey AGM’s

   You obviously don’t work in WHC and don’t understand everything that goes into the Bayer IUD’s. The reps handle everything from contracting to r several residency trainings annually, replacements, playing the “FRM” role, training new providers...

   Bayer

   anonymous

   Apr 23, 2024 at 10:04 PM

3. 

   Electric vehicle garage fire

   Contact the press!!! Please and thanks

   AstraZeneca

   anonymous

   Apr 23, 2024 at 10:03 PM

4. 

   Cell therapy started layoff yesterday. Other departments will follow

   BMS = Dumpster Fire.

   Bristol-Myers Squibb

   anonymous

   Apr 23, 2024 at 10:02 PM

5. 

   Allergy Territory Account Specialist

   Remibrutinib is also in development for food allergy and hidradenitis suppurativa due to the Q1 investor presentation.

   Novartis

   anonymous

   Apr 23, 2024 at 10:00 PM

6. 

   BRAD clueless

   Things are so much different since the “reorg”, and not in a good way. Leadership totally disconnected, losing good reps daily. Seems like everyone sees it but them. Hopefully “they” figure it out.

   Bausch & Lomb

   anonymous

   Apr 23, 2024 at 9:57 PM

7. 

   WHC reorganization is here!

   Funny you say that. Kerendia is quite literally one of a small handful of drugs that are keeping the entire company afloat. Get back to your home study materials.

   Bayer

   anonymous

   Apr 23, 2024 at 9:56 PM

8. + Show More